Table 1.
No Sedation (n=40) | Mild Sedation (n=9) | Heavy Sedation (n=9) | Pharmacological Paralysis (n=17) | All Groups (n=75) | p-value** | |
---|---|---|---|---|---|---|
Age | 64.6 ± 11.4 | 63.6 ± 10.3 | 64.0 ± 12.2 | 62.8 ± 12.6 | 64.0 ± 11.5 | 0.98 |
Baseline NIHSS | 17.3 ± 4.5 | 19.4 ± 8.3 | 21.0 ± 5.5 | 21.2 ± 4.0 | 18.9 ± 5.3 | 0.03 |
Male Gender | 26 (65.0%) | 4 (44.4%) | 3 (33.3%) | 11 (64.7%) | 44 (58.7%) | 0.26 |
Non-White | 7 (17.5%) | 2 (22.2%) | 1 (11.1%) | 5 (29.4%) | 15 (20.0%) | 0.68 |
Atrial Fibrillation | 11 (27.5%) | 2 (22.2%) | 2 (22.2%) | 3 (17.7%) | 18 (24.3%) | 0.95 |
Baseline Glucose | 120.1 ± 42.6 | 116.1 ± 19.4 | 169.0 ± 104.2 | 125.2 ± 38.8 | 126.6 ± 52.5 | 0.68 |
Baseline SBP | 143.8 ± 22.6 | 150.1 ± 10.4 | 143.7 ± 20.9 | 147.4 ± 21.0 | 145.4 ± 20.7 | 0.83 |
Left Hemisphere Involved | 20 (50.0%) | 6 (66.7%) | 8 (88.9%) | 11 (64.7%) | 45 (60.0%) | 0.17 |
Aphasia Present | 19 (47.5%) | 6 (66.7%) | 8 (88.9%) | 11(64.7%) | 44 (58.7%) | 0.11 |
ICAT occlusion | 7 (18.4) | 1 (11.1) | 2 (22.2) | 8 (47.1) | 18 (24.7) | 0.12 |
Onset to IV treatment (min) | 141.6 ± 33.5 | 127.7 ± 38.3 | 139.1 ± 28.4 | 139.0 ± 25.5 | 139.1 ± 31.6 | 0.75 |
Received IA treatment | 25 (62.5%) | 8 (88.9%) | 8 (88.9%) | 12 (70.6%) | 53 (70.7%) | 0.31 |
Onset to IA treatment (min) | 231.6 ± 55.3 | 234.6 ± 55.0 | 238.5 ± 35.4 | 236.8 ± 57.7 | 234.3 ± 51.9 | 0.99 |
Duration of procedure (min) | 111.2 ± 59.3 | 119.9 ± 65.9 | 150.9 ± 44.4 | 136.8 ± 65.7 | 123.1 ± 60.5 | 0.26 |
Categorical variables are described using n (%), and continuous variables are presented as mean ± standard deviation
P-values represent variation across all 4 sedation categories.